Variant report
Variant | nsv826280 |
---|---|
Chromosome Location | chr12:20968746-20983688 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs377570761 | chr12:20968752-20968753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563634489 | chr12:20968755-20968756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529471627 | chr12:20968759-20968760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549294341 | chr12:20968766-20968767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566179004 | chr12:20968772-20968773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs370551723 | chr12:20968778-20968779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528530013 | chr12:20968782-20968783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370172063 | chr12:20968794-20968795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374604069 | chr12:20968800-20968801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571633334 | chr12:20968804-20968805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533097921 | chr12:20968807-20968808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537425469 | chr12:20968808-20968809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556524453 | chr12:20968809-20968810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10734710 | chr12:20968828-20968829 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs193031273 | chr12:20968832-20968833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555227672 | chr12:20968867-20968868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569599313 | chr12:20968875-20968876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371677382 | chr12:20968876-20968877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74464403 | chr12:20968880-20968881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs577248265 | chr12:20968935-20968936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369901421 | chr12:20968947-20968948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs67516591 | chr12:20968982-20968983 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs563680912 | chr12:20968990-20968991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573955359 | chr12:20969001-20969002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75589443 | chr12:20969071-20969072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559662228 | chr12:20969102-20969103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547464767 | chr12:20969132-20969133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528601744 | chr12:20969149-20969150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551617211 | chr12:20969196-20969197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs374777043 | chr12:20969228-20969229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369664536 | chr12:20969252-20969253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565355207 | chr12:20969254-20969255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373226117 | chr12:20969315-20969316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs1850011 | chr12:20969323-20969324 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs142309919 | chr12:20969360-20969361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569973037 | chr12:20969383-20969384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183752439 | chr12:20969390-20969391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369359476 | chr12:20969408-20969409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565773614 | chr12:20969433-20969434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534796849 | chr12:20969497-20969498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557479866 | chr12:20969521-20969522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577398924 | chr12:20969522-20969523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577311705 | chr12:20969528-20969529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536658795 | chr12:20969534-20969535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556493227 | chr12:20969586-20969587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574296733 | chr12:20969601-20969602 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187603307 | chr12:20969619-20969620 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371480876 | chr12:20969620-20969621 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192085757 | chr12:20969625-20969626 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539571680 | chr12:20969626-20969627 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 16397240 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21364760 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Schizophrenia | 23813976 | CNVD |
Schizophrenia | 21346763 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:20964600-20969600 | Weak transcription | A549 | lung |
2 | chr12:20967400-20975400 | Weak transcription | Liver | Liver |
3 | chr12:20969600-20970400 | Strong transcription | A549 | lung |
4 | chr12:20970400-20975200 | Weak transcription | A549 | lung |
5 | chr12:20974200-20975400 | Active TSS | Hela-S3 | cervix |
6 | chr12:20975200-20977200 | Active TSS | A549 | lung |
7 | chr12:20975400-20976000 | Enhancers | Liver | Liver |
8 | chr12:20975400-20976200 | Flanking Active TSS | Hela-S3 | cervix |
9 | chr12:20976000-20981400 | Weak transcription | Liver | Liver |
10 | chr12:20976200-20976600 | Enhancers | Hela-S3 | cervix |
11 | chr12:20976600-20976800 | Flanking Active TSS | Hela-S3 | cervix |
12 | chr12:20976800-20977000 | Active TSS | Hela-S3 | cervix |
13 | chr12:20977200-20977600 | Flanking Active TSS | A549 | lung |
14 | chr12:20977600-20979000 | Active TSS | A549 | lung |
15 | chr12:20979000-20980200 | Flanking Active TSS | A549 | lung |
16 | chr12:20980200-20984000 | Enhancers | A549 | lung |
17 | chr12:20981400-20983600 | Enhancers | Liver | Liver |
18 | chr12:20983200-20983400 | Enhancers | Hela-S3 | cervix |
19 | chr12:20983400-20996400 | Weak transcription | Hela-S3 | cervix |
20 | chr12:20983600-20995600 | Weak transcription | Liver | Liver |